HER2 Support Group Forums - View Single Post - MD Anderson and Summit Therapeutics partner to accelerate ivonescimab development

News · 07-25-2024, 10:01 AM

The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement for the purpose of accelerating the development of ivonescimab.

More...

07-25-2024, 10:01 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,125	MD Anderson and Summit Therapeutics partner to accelerate ivonescimab development The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement for the purpose of accelerating the development of ivonescimab. More...